Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274☆
Galsky, M. D., Gschwend, J. E., Milowsky, M. I., Schenker, M., Valderrama, B. P., Tomita, Y., Bamias, A., Lebret, T., Shariat, S. F., Park, S. H., Agerbaek, M., Jha, G., Stenner, F., Ye, D., Giudici, F., Connors, J., Gupta, S., Chhibber, A., Zhang, J. & Bajorin, D. F. & 1 others, , Jan 2026, In: Annals of Oncology. 37, 1, p. 69-78 10 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations -
Aktualisierung S3-Leitlinie zum metastasierten Prostatakarzinom – Leitlinienempfehlungen und Expertenkonsens
Translated title of the contribution :Update of S3 guideline on metastatic prostate cancer—guideline recommendations and expert consensus Research output: Contribution to journal › Article › peer-review
-
Assessment of nephrotoxicity following lutetium-177 PSMA I&T radioligand therapy: a comparative study with docetaxel chemotherapy
Kirchhoff, F. P., Steinhelfer, L., Pfob, C. H., Lapa, C., Hartrampf, P. E., Buck, A. K., Tauber, R., Schäfer, H., Schmaderer, C., Fütterer, C., Haller, B., Jahnen, M., Knorr, K., Gschwend, J. E., Weber, W. A., Eiber, M. & Lunger, L., 2026, (Accepted/In press) In: European Journal of Nuclear Medicine and Molecular Imaging.Research output: Contribution to journal › Article › peer-review
Open Access